Boyanov & Co. has a strong foothold in the pharmaceuticals industry, where they advise international pharmaceutical and generics companies, namely AstraZeneca, AbbVie and Pfizer Bulgaria, on IP and trade mark rights, patent protection and litigation, price regulation and medical reimbursements, while also being well versed in related competition and antitrust matters. Kina Chuturkova and Peter Petrov jointly lead the practice, with the former specialising in litigation and arbitrations, and the latter handling regulatory advice and pharmaceutical antitrust. Nedyalka Novakova supports the team on a range of issues including day-to-day advice to pharma companies and contractual support for clinical trials.
Legal 500 Editorial commentary
Mentions
Profile
Work Department
Competition.
Position
• Partner, Head of Competition and Antitrust;
• Commercial, Competition, Corporate, Financial markets, Employment, TMT.
Career
• Partner, BOYANOV & Co. (2008 – to date);
• Senior Associate, Borislav Boyanov & Co. (2006 – 2008);
• International Secondment to Allen & Overy, London (2004);
• Associate, Borislav Boyanov & Co. (2001 – 2006);
• Trainee Attorney, Borislav Boyanov & Co. (1998 – 2001).
Languages
Bulgarian, English, Russian, Spanish.
Memberships
Sofia Bar Association, Council of the European Forum of the International Bar Association.
Education
• Faculty of Law, Sofia University St. Kliment Ohridski, MA in Law (1999);
• Academy of American and International Law, The Center for American and International Law (formerly, The Southwestern Legal Foundation), Dallas, USA (2002);
• International Secondment to Allen & Overy, London (2004).
Content supplied by Boyanov & Co.
Testimonials
Collated independently by Legal 500 research team.
‘Excellent team that understands business needs.’
‘Peter Petrov is renowned for his expertise in healthcare and life sciences - right to the point and no waste of time.’
‘Boyanov & Co clearly stands out of the other law offices in Bulgaria. Professionalism, industry knowledge and high responsiveness make Boyanov & Co an irreplaceable advisor in the country.’
‘Peter Petrov is always available to advise and assist with their knowledge and experience.’
‘Boyanov Team's uniqueness lies in its deep specialisation and unparalleled expertise in the medical device industry. The team has a proven track record of successfully navigating complex regulatory landscapes, ensuring compliance with both domestic and international standards. Their client-centric approach is another standout feature, investing significant time in understanding the specific needs and challenges of client needs, which allows them to provide tailored legal solutions.’
‘Peter Petrov at Boyanov brings a wealth of knowledge in specialised areas such as regulatory compliance, competition law and corporate law, making the team exceptionally well-rounded. Peter's resource availability is another key strength, having access to exclusive databases and industry specific know-how, which enhances his research and advisory capabilities. Peter's ability to deliver results consistently, even in the most challenging cases, makes him to stand out with every opportunity.’
Key clients
- Neola Pharma EOOD
- F. Hoffmann La Roche
- AbbVie
- ARPharM Bulgaria
- Bayer
- Novartis
- GSK
- Celgene Corporation
- Merck
- Medtronic
- Pfizer Bulgaria
- Anika Therapeutics
- AstraZeneca
- Baxter Health
- Stada
- ICON Plc
- Ferring Pharmaceuticals
- Grünenthal
- Allergan, Inc.
- Roche Bulgaria
- Sandoz
- Pharmapro
- Syneos Health
- Sofmedica
- Arcadia Consumer Healthcare
- Ottobock
- MagnaPharm
Work highlights
Represented AbbVie in a litigation against the secondary legislation instituting the Bulgarian pharmaceutical claw-back system, responsible for collecting more than EUR 100m in payments from the pharmaceutical industry.
Advised ARPharM on reform proposals for the primary and secondary regulation of the Bulgarian reimbursement system, to ensure a fairer risk allocation between the public health insurance scheme (NHIF) and the pharmaceutical industry.